Correlation Between Visual Acuity and Duration of Symptoms in the ABC Trial - A Double-Masked, Randomised Controlled Trial of Intravitreal Avastin (Bevacizumab) Injections for the Treatment of Choroidal Neovascularization (CNV) in Age-Related Macular Degeneration (AMD)

被引：0
|
作者：
Esposti, S. Degli [1 ]
Patel, P. J. [2 ]
Tufail, A. [2 ]
机构：
[1] Moorfields Eye Hosp, London, England
[2] Moorfields Eye Hosp, NIHR Biomed Res Ctr Ophthalmol, London, England
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2010年 / 51卷 / 13期
关键词：
age-related macular degeneration; vascular endothelial growth factor; visual acuity;
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
89
引用
收藏
页数：2
相关论文
共 49 条
  • [31] Relationships between clinical measures of visual function and anatomic changes associated with bevacizumab treatment for choroidal neovascularization in age-related macular degeneration
    Y B Ünver
    G A Yavuz
    N Bekiroğlu
    P Presti
    W Li
    S H Sinclair
    Eye, 2009, 23 : 453 - 460
  • [32] A randomised prospective double-masked exploratory study comparing combination photodynamic treatment and intravitreal ranibizumab vs intravitreal ranibizumab monotherapy in the treatment of neovascular age-related macular degeneration
    Vallance, J. H.
    Johnson, B.
    Majid, M. A.
    Banerjee, S.
    Mandal, K.
    Bailey, C. C.
    EYE, 2010, 24 (10) : 1561 - 1567
  • [33] VISUAL OUTCOMES AND GROWTH FACTOR CHANGES OF TWO DOSAGES OF INTRAVITREAL BEVACIZUMAB FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION A Randomized, Controlled Trial
    Lai, Timothy Y. Y.
    Liu, David T. L.
    Chan, Kwok-Ping
    Luk, Fiona O. J.
    Pang, Chi-Pui
    Lam, Dennis S. C.
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2009, 29 (09): : 1218 - 1226
  • [34] External beam irradiation of subfoveal choroidal neovascularization complicating age related macular degeneration: 1 year results of a prospective, double-masked, randomized pilot clinical trial.
    Marcus, DM
    Sheils, WC
    McIntosh, SB
    Johnson, MH
    Leibach, DB
    Alexander, J
    Maguire, AM
    Samy, CN
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2000, 41 (04) : S179 - S179
  • [35] Improvement of Retinal Function in Early Age-Related Macular Degeneration After Lutein and Zeaxanthin Supplementation: A Randomized, Double-Masked, Placebo-Controlled Trial
    Ma, Le
    Dou, Hong-Liang
    Huang, Yang-Mu
    Lu, Xin-Rong
    Xu, Xian-Rong
    Qian, Fang
    Zou, Zhi-Yong
    Pang, Hong-Lei
    Dong, Peng-Cheng
    Xiao, Xin
    Wang, Xun
    Sun, Ting-Ting
    Lin, Xiao-Ming
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2012, 154 (04) : 625 - 634
  • [36] Intravitreal aflibercept 8 mg in neovascular age-related macular degeneration (PULSAR): 48-week results from a randomised, double-masked, non-inferiority, phase 3 trial
    Lanzetta, Paolo
    Korobelnik, Jean-Francois
    Heier, Jeffrey S.
    Leal, Sergio
    Holz, Frank G.
    Clark, W. Lloyd
    Eichenbaum, David
    Iida, Tomohiro
    Xiaodong, Sun
    Berliner, Alyson J.
    Schulze, Andrea
    Schmelter, Thomas
    Schmidt-Ott, Ursula
    Zhang, Xin
    Vitti, Robert
    Chu, Karen W.
    Reed, Kimberly
    Rao, Rohini
    Bhore, Rafia
    Cheng, Yenchieh
    Sun, Wei
    Hirshberg, Boaz
    Yancopoulos, George
    Wong, Tien Y.
    LANCET, 2024, 403 (10432): : 1141 - 1152
  • [37] Triterpenoid saponin-mediated recovery of visual deficits in age-related macular degeneration (AMD): Double-blind, placebo-controlled, randomised clinical trial
    Lee, Yunhee
    Ahn, Eun-Jung
    Chae, Soo-Wan
    Hussain, Ali Aijaz
    ASIA-PACIFIC JOURNAL OF OPHTHALMOLOGY, 2025, 14 (01):
  • [38] Interim safety analysis of a multicenter randomized prospective double masked placebo controlled trial of apheresis in pre-angiogenic age-related macular degeneration (AMD)
    Davis, RL
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2002, 43 : U596 - U596
  • [39] Randomised controlled trial over 92 weeks using bevacizumab for the treatment of neovascular age-related macular degeneration comparing a treatment regime with 12 weekly regular injections to one with injections on an as-needed basis.
    Bishop, Paul N.
    Roberts, Stephen
    Aslam, Tariq
    Charles, Stephen
    Stanga, Paulo E.
    Parkes, Jeremy
    Mahmood, Sajjad
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [40] Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials
    Heier, Jeffrey S.
    Lad, Eleonora M.
    Holz, Frank G.
    Rosenfeld, Philip J.
    Guymer, Robyn H.
    Boyer, David
    Grossi, Federico
    Baumal, Caroline R.
    Korobelnik, Jean-Francois
    Slakter, Jason S.
    Waheed, Nadia K.
    Metlapally, Ravi
    Pearce, Ian
    Steinle, Nathan
    Francone, Anibal A.
    Hu, Allen
    Lally, David R.
    Deschatelets, Pascal
    Francois, Cedric
    Bliss, Caleb
    Staurenghi, Giovanni
    Mones, Jordi
    Singh, Rishi P.
    Ribeiro, Ramiro
    Wykoff, Charles C.
    LANCET, 2023, 402 (10411): : 1434 - 1448
12345